The 2001 Canadian hypertension recommendations: take-home messages

被引:0
|
作者
Campbell, NRC [1 ]
Drouin, D
Feldman, RD
机构
[1] Univ Calgary, Dept Internal Med, Fac Med, Calgary, AB, Canada
[2] Sante Publ Quebec, Beauport, PQ, Canada
[3] Univ Western Ontario, John P Robarts Res Inst, London, ON, Canada
[4] Univ Western Ontario, Dept Med, London, ON, Canada
[5] Univ Western Ontario, Dept Physiol, London, ON, Canada
[6] Univ Western Ontario, Dept Pharmacol & Toxicol, London, ON, Canada
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Mrs. J, a 72-year-old woman whom you are treating for continuing hip pain related to arthritis (diclofenac 75 mg/d), has been relatively healthy, but her blood pressure has been increasing recently. Over the last 3 visits it has been 184/92 mm Hg on average. Mrs. J is physically active and uninterested in dietary advice. She is a nonsmoker who does not drink alcohol. Her body mass index is 26 kg/m(2), and physical examination reveals a pulsatile mass in the upper abdomen. The rest of the examination is unremarkable. Electrolyte and creatinine levels, complete blood count, and urinalysis and electrocardiography results are all within normal ranges. The fasting glucose level is 5.6 mmol/L, total cholesterol 5.4 mmol/L, high-density lipoprotein cholesterol 1.1 mmol/L and triglycerides 1.3 mmol/L. Ultrasonography of the abdomen shows a tortuous aorta with no aneurysm. What drugs are recommended as starting therapy? Once this therapy has been started, what will you add as a second drug? As a third drug? Does the most recent evidence concerning treatment of hypertension, reflected in the 2001 revisions of the Canadian recommendations for the management of hypertension, mandate any changes from previous practice in the approach to therapy?
引用
收藏
页码:661 / 668
页数:8
相关论文
共 50 条
  • [21] PATIENT-EDUCATION-2000 - TAKE-HOME MESSAGES FROM THIS CONGRESS
    TATTERSALL, R
    [J]. PATIENT EDUCATION AND COUNSELING, 1995, 26 (1-3) : 373 - 377
  • [22] Nonadiabatic Excited State Dynamics of Organic Chromophores: Take-Home Messages
    Chakraborty, Pratip
    Liu, Yusong
    McClung, Samuel
    Weinacht, Thomas
    Matsika, Spiridoula
    [J]. JOURNAL OF PHYSICAL CHEMISTRY A, 2022, 126 (36): : 6021 - 6031
  • [23] Common variable immunodeficiency and respiratory complications: take-home messages for the clinician
    Wasserman, Richard L.
    [J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2020, 124 (05) : 414 - 415
  • [25] TAKE-HOME MESSAGE
    April, Michael D.
    Long, Brit
    [J]. ANNALS OF EMERGENCY MEDICINE, 2018, 71 (03) : E9 - E11
  • [26] TAKE-HOME EXAMINATION
    FREEDMAN, AS
    [J]. PEABODY JOURNAL OF EDUCATION, 1968, 45 (06): : 343 - 347
  • [27] 'TAKE-HOME EXAM'
    WALTNERTOEWS, D
    [J]. PRISM INTERNATIONAL, 1976, 15 (2-3): : 186 - 186
  • [28] TAKE-HOME POINTS
    Dr Eichenbaum
    [J]. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2020, 40 : 10 - 11
  • [29] Take-home toxins
    Worthington, K
    [J]. AMERICAN JOURNAL OF NURSING, 2001, 101 (09) : 88 - 88
  • [30] TAKE-HOME MESSAGE
    Meltzer, Andrew C.
    Mazer-Amirshahi, Maryann
    [J]. ANNALS OF EMERGENCY MEDICINE, 2016, 68 (06) : 717 - 718